濮阳东方医院看男科技术比较专业-【濮阳东方医院】,濮阳东方医院,濮阳东方看男科病技术很权威,濮阳东方医院做人流手术口碑好吗,濮阳东方医院男科口碑很好,濮阳东方医院治疗阳痿收费比较低,濮阳东方妇科评价好专业,濮阳东方男科医院几点上班
濮阳东方医院看男科技术比较专业濮阳东方医院妇科治病不贵,濮阳市东方医院技术比较专业,濮阳东方男科医院看病专业,濮阳东方医院男科治疗阳痿价格,濮阳东方医院男科看阳痿技术可靠,濮阳东方医院割包皮手术很好,濮阳东方看妇科病收费合理
MSAN DIEGO (KGTV) -- Mayor Kevin Faulconer announced Monday that the city has repaired 655 miles of roads so far, which is ahead of schedule to meet the goal of 1,000 miles of roads by 2020.Averaging more than 300 miles per year puts the city ahead of schedule, even as a small percentage of repairs has required taking the roads down to the dirt.RELATED: San Diego County approves million road resurfacing project“The unprecedented investment we’ve made in road repair is showing results with more smooth streets in our neighborhoods,” Mayor Faulconer said. “There’s still a lot more work that needs to be done, but we’re making significant progress on an issue that is a top concern for so many residents.”Within the first two fiscal years of the pledge, the city fixed 595 miles of roads. Last year, an assessment showed the overall condition of city streets rose to 72 on a scale of zero to 100.RELATED: Mayor vows to fix more roads in San DiegoMayor Faulconer says if they do complete the work ahead of schedule they will assess additional roads and keep going.Click here to report potholes and road issues. Click on the image below to see repairs happening in your area: 1204
Moderna says that it will file for Emergency Use Authorization for its COVID-19 vaccine candidate after a primary efficacy analysis showed it to be 94% effective in preventing the virus.In a press release on Monday, Moderna said that a primary efficacy study of its vaccine candidate showed it to be 94% effective in preventing COVID-19 infection and that no participants who received the vaccine developed a severe case of the virus.According to Moderna's press release, of the 30,000 participants who took part in a Phase 3 trial, 196 have since contracted the virus. Of those participants, only 11 had received the vaccine — the other 185 had received a placebo. Only 30 people who took part in the trial have developed a severe case of the virus, all of whom received a placebo shot.The findings are consistent with efficacy figures released by Moderna just weeks ago. Moderna is the second U.S. company to seek Emergency Use Authorization for a COVID-19 vaccine. Pfizer submitted its application earlier this month.Like Pfizer's vaccine, the Moderna vaccine requires two shots that need to be taken 28 days apart. It also needs to be stored at ultra-cold temperatures before injection.Health experts say it is encouraging that there are multiple COVID-19 vaccine candidates that are nearing authorization, as the public will be less reliant on one vaccine in the unlikely event of safety issues.Experts like Dr. Anthony Fauci have said that there is a chance that some Americans in high-risk populations could begin receiving the vaccine in the coming weeks. However, COVID-19 vaccines won't be available for widespread use until the spring.Moderna's vaccine was funded in part by country singer Dolly Parton, who donated million to COVID-19 research at Vanderbilt University earlier this year. 1810
MISSOURI (KMOV) -- A state representative from western Missouri wants to ban porn access for everyone in the state unless you pay up.Representative Jim Neely (R-Cameron) says the idea behind his bill is simple: protecting kids.The bill says a distributor who makes or sells a product that is accessible to the internet, like a phone or a computer would be required to install a blocking software that would prevent the device from accessing obscene material.Neely says it would apply to all porn. A person could have the blocking software removed if they prove they are more 18-years-old and pays a deactivation fee. The money would go into a fund called the “Human Trafficking and Child Exploitation Prevention Fund.”When pressed on how the blocking software would work, Neely said it would be similar to how schools block students from websites, but when pressed he admitted, he wasn’t sure of the logistics.“I’m a physician, I don’t know computers,” said Neely in a phone interview.Cindy Wallace is the manager of Simple Pleasures Boutique in south St. Louis. They have a large adult video collection.“I just don’t see how they would be able to do it number one and number two, I think there are more things in every single state to worry about besides people watching porn,” said Wallace.The ACLU of Missouri said the bill adds an “unreliable and unconstitutional filter.”“While this legislation may seem like a way to make communities safer, it will cause more harm than good by censoring constitutionally protected speech and creating far-reaching, long-term consequences when it comes to Missourians’ privacy,” said Jeffrey Mittman, executive director, ACLU of Missouri“This bill will invade the privacy of Missourians who have not engaged in any criminal act.”The bill says if a distributor fails to block the prohibited sites, they could face a civil lawsuit.News 4 asked Attorney General Josh Hawley about the proposed legislation but he said he would have to read up on it.Nearly identical legislation was introduced in Alabama and Rhode Island.The bill has not yet gone to committee. 2112
MILWAUKEE -- Six cars were damaged Friday when light poles fell across traffic lanes on I-43 near Milwaukee.According to the Milwaukee County Sheriff's Office, the driver of a red pick-up truck heading northbound hit both of the light poles in the median just before 3:30 p.m. A witness at a law firm off Hampton Avenue said she saw the truck drive up onto the median and hit one pole, before continuing on to hit a second. "Unfortunately one of them kind of struck the side of the car, put a hole in the door, took a mirror out," said Jim Lovering, whose daughter called him after swerving to avoid the two poles.Lovering's 7-month-old grandson was also in the car. "Just missed the windshield, which was a blessing," said Lovering. The camera caught deputies taking away the driver of the red truck in handcuffs. Authorities have not yet released any information confirming an arrest, or possible charges. The accident caused backups for miles during rush hour, as crews worked to remove the poles from the roadway. No one in any of the cars was injured. "It was just nice that she had the space to maneuver and without hitting anybody else or causing any further damage," said Lovering. "It could be potentially you know a serious accident. Thank God it didn't happen." 1341
Moderna announced on Thursday that it had enrolled 30,000 participants in its Phase 3 COVID-19 vaccine trial, with more than 11,000 of those participants from communities of color.More than 25,650 participants have already received their second vaccination, the company said in a press release.The company added that the study also includes 7,000 participants over the age of 65.“Completing enrollment of the Phase 3 COVE study is an important milestone for the clinical development of mRNA-1273, our vaccine candidate against COVID-19," said Stéphane Bancel, Chief Executive Officer of Moderna in the news release. "We are indebted to all of the participants in the study. We would also like to thank the investigators and our partners at clinical trial sites, including our partners from PPD and the NIH, as well as the dedicated Moderna team for their support in completing enrollment. Moderna is committed to rigorous scientific research and the highest data quality standards. We will continue to work in collaboration with regulators to advance mRNA-1273, which we hope will help defeat the COVID-19 pandemic.”CNN reported that for Moderna to apply to the FDA for emergency use authorization, the following three things need to happen:53 of the 30,000 participants would need to become sick with COVID-19, which is expected to occur in the second half of November.40 of the 53 participants who do become ill with COVID-19 need to have received the placebo, which would show that the vaccine is 75% effective.Make sure enough time has passed to see if participants develop side effects.According to CNN, Moderna is the first company to start US clinical trials of a COVID-19 vaccine. 1696